Search research articles
Contact Us
Filters
Showing results (51-60 of 151) with videos related to
Page
of 16
Sort By:
Haematologica
|
July 20, 2004
Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <or=50 years old in first complete remission: results of the EORTC ALL-3 trial
Boris Labar, Stefan Suciu, Robert Zittoun, et al.
Haematologica
|
November 21, 2007
Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma
Gösta Gahrton, Simona Iacobelli, Giuseppe Bandini, et al.
Haematologica
|
August 10, 2012
Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome
Barbara Deschler, Gabriele Ihorst, Uwe Platzbecker, et al.
British Journal of Haematology
|
August 30, 2002
Abnormal WT1 expression in the CD34-negative compartment in myelodysplastic bone marrow
Jeroen P Van Dijk, Gertrudis H J N Knops, Louis T F Van De Locht, et al.
Annals of Hematology
|
September 3, 2021
The anemia-independent impact of myelodysplastic syndromes on health-related quality of life
Hanneke J C M Wouters, Annette Conrads-Frank, Karin A Koinig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2012
Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): A retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma working party of the European Group for Blood and Marrow Transplantation
Kate Cwynarski, Anja van Biezen, Liesbeth de Wreede, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 24, 2015
Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
Aleksandar Radujkovic, Cesare Guglielmi, Stefania Bergantini, et al.
Haematologica
|
September 2, 2004
Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups
Sergio Amadori, Stefan Suciu, Roel Willemze, et al.
Blood
|
November 21, 2007
Gene transactivation without direct DNA binding defines a novel gain-of-function for PML-RARalpha
Sake van Wageningen, Marleen C Breems-de Ridder, Jeannet Nigten, et al.
The Journal of Clinical Investigation
|
December 3, 2005
A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia
Björn de Rijke, Agnes van Horssen-Zoetbrood, Jeffrey M Beekman, et al.
Page
of 16
Search research articles
Search
Showing results (51-60 of 151) with videos related to
Sort By:
Page
of 16
Haematologica
|
July 20, 2004
Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <or=50 years old in first complete remission: results of the EORTC ALL-3 trial
Boris Labar, Stefan Suciu, Robert Zittoun, et al.
Haematologica
|
November 21, 2007
Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma
Gösta Gahrton, Simona Iacobelli, Giuseppe Bandini, et al.
Haematologica
|
August 10, 2012
Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome
Barbara Deschler, Gabriele Ihorst, Uwe Platzbecker, et al.
British Journal of Haematology
|
August 30, 2002
Abnormal WT1 expression in the CD34-negative compartment in myelodysplastic bone marrow
Jeroen P Van Dijk, Gertrudis H J N Knops, Louis T F Van De Locht, et al.
Annals of Hematology
|
September 3, 2021
The anemia-independent impact of myelodysplastic syndromes on health-related quality of life
Hanneke J C M Wouters, Annette Conrads-Frank, Karin A Koinig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2012
Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): A retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma working party of the European Group for Blood and Marrow Transplantation
Kate Cwynarski, Anja van Biezen, Liesbeth de Wreede, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 24, 2015
Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
Aleksandar Radujkovic, Cesare Guglielmi, Stefania Bergantini, et al.
Haematologica
|
September 2, 2004
Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups
Sergio Amadori, Stefan Suciu, Roel Willemze, et al.
Blood
|
November 21, 2007
Gene transactivation without direct DNA binding defines a novel gain-of-function for PML-RARalpha
Sake van Wageningen, Marleen C Breems-de Ridder, Jeannet Nigten, et al.
The Journal of Clinical Investigation
|
December 3, 2005
A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia
Björn de Rijke, Agnes van Horssen-Zoetbrood, Jeffrey M Beekman, et al.
Page
of 16